The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPowerhouse Ener Regulatory News (PHE)

Share Price Information for Powerhouse Ener (PHE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.925
Bid: 0.90
Ask: 0.95
Change: 0.025 (2.70%)
Spread: 0.05 (5.556%)
Open: 0.925
High: 0.95
Low: 0.92
Prev. Close: 0.925
PHE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 Aug 2022 07:00

RNS Number : 1442X
Powerhouse Energy Group PLC
25 August 2022
 

 

 25 August 2022

 

Powerhouse Energy Group plc

("Powerhouse" or the "Company")

 

Half Year Report

 

 

Powerhouse Energy Group plc (AIM: PHE), the UK technology company commercialising hydrogen production from plastic, is pleased to announce its unaudited interim results for the six months ended 30 June 2022.

 

Highlights

 

 

Commercial Development

 

·

Continued support of Peel NRE's development of the proposed first commercial scale application of Powerhouse's technology at the Protos Energy Park in Cheshire, UK. Peel NRE has shortlisted two potential contractors for the construction works and is currently seeking the necessary finance. Identifying potential contractors took significantly longer than expected due in part to the impact of the Covid pandemic. Further work is yet required to finalise the cost of construction, which is also being impacted by the high rates of inflation. A revised estimate of the construction programme and targeted time for commercial deployment will be made as soon as it can be established.

·

Secured exclusivity and a supply chain with a Thermal Conversion Chamber manufacturer in the UK.

·

Post period end signed a non-binding term sheet setting out the heads of terms for Powerhouse to take a 50% shareholding in the Peel NRE Ltd special purpose vehicle, Protos Plastics-to Hydrogen No 1 Ltd.

·

Post period end agreed heads of terms ("HoTs") with Hydrogen Utopia International Plc (AQSE: HUI) ("HUI") for the proposed joint development of a site at Lanespark in Co. Tipperary in the Rep of Ireland.

·

Post period end agreed HoTs with HUI for the proposed joint development of a site in Konin, within the Wielkopolska province of Poland.

 

 

Technology and Innovation

 

·

Unveiled plans for a £1.3m investment to create a Global Technology & Innovation Centre by Q2 2023, to support the development of the technology coupled with serving as a sales development centre. Initial pre-payment of £193k made to the supplier for the design and supply of the test pyrolysis reactor.

·

Evolution and adoption of a more flexible business model to provide a pipeline of opportunities to implement PHE's DMG technology.

 

 

Financial Performance

 

·

Revenues for the half year of £352k (H1 2021: £373k).

·

Gross Profit for period increased to £79.9k (2021: £16.7k).

·

£7.54m cash at bank at 30 June 2022.

 

 

Organisation and Growth

 

·

Completion of a strategic review of the business with a clear path to commerciality and technical roadmap completed by our CEO and embraced by the Company.

·

Post period end changes to the Board of Directors, including the resignation of Paul Drennan-Durose as CEO and of two Non-Executive Directors.

·

Post period end appointment of Paul Emmitt to Chief Operating Officer.

 

 

Statement from Keith Riley, Interim non-executive Chairman and acting CEO of Powerhouse Energy Group Plc

"Progress has been made in the first half of 2022 as we developed our business model to be more flexible and retain more control over our proprietary technology. We continue with our plans to develop a global technology and innovation centre to develop our knowhow and breadth of application.

"With the refocusing of our strategy and additional flexibility of our business model implemented, we are encouraged to see increased levels of interest on an international level in the Powerhouse proposition. Post period end we have announced that we have signed two Heads of Terms with Hydrogen Utopia, for two projects outside of the UK; one in Ireland and the other in Poland. Both of these territories are key markets for Powerhouse as they give the company positioning within the EU from where further business expansion can be made.; Poland is a European leader in revitalising its economy towards net zero carbon emissions, while Ireland is in the process of establishing its hydrogen strategy with view to becoming a major player in the emerging hydrogen economy.

"There have been additional changes to the management team post period end, however at working level, the business continues to grow in strength and advance the commercial implementation of its technology. I would like to thank Paul Drennan-Durose, Gill Weeks, Myles Kitcher and James Greenstreet for their contribution to the business and wish them will in their future endeavors. Paul Emmitt has been appointed to Chief Operating Officer. He has been Chief Technical Officer since July 2021 and has over twenty years of engineering and operational management experience both in the UK and overseas in the oil, gas, energy-from-waste and chemical industries, he is well placed to progress the Company's strategy. Chief Financial Officer, Chris Vanezis, is on paternity leave and Ben Brier is acting CFO during Chris' absence,

"There is much work to be done in the development of our projects as we continue on our path to commercial implementation. The changes implemented in our commercial relationships made during the first half of this year will create the foundation for the growth of the Company in the years to come. We look forward to updating investors on our progress as we move through the financial year."

For more information, contact:

 

Powerhouse Energy Group Plc

Paul Drennan-Durose and Keith Riley

 

 

powerhouse@tavistock.co.uk

 

WH Ireland Limited (Nominated Adviser)

James Joyce and Megan Liddell

 

 

+44 (0) 207 220 1666

Turner Pope Investments (TPI) Ltd (Joint Broker)

Andrew Thacker and James Pope

 

 

+44 (0) 203 657 0050

Tavistock (Financial PR)

Simon Hudson, Nick Elwes and Heather Armstrong

powerhouse@tavistock.co.uk

 

 

 

About Powerhouse Energy Group plc

 

Powerhouse Energy has developed a proprietary process technology - DMG® - which can utilise waste plastic, end-of-life-tyres, and other waste streams to convert them efficiently and economically into syngas from which valuable products such as chemical precursors, hydrogen, electricity, and other industrial products may be derived. Powerhouse's technology is one of the world's first proven, distributed, modular, hydrogen from waste process.

 

Powerhouse's process produces low levels of safe residues and requires a small operating footprint, making it suitable for deployment at enterprise and community level.

 

Powerhouse is quoted on the London Stock Exchange's AIM Market under the ticker: PHE and is incorporated in the United Kingdom.

 

For more information see www.powerhouseenergy.co.uk

 

 

Statement of Comprehensive Income

 

(Unaudited)

Six months

(Unaudited)

Six months

(Audited)

Year

 

ended

ended

Ended

 

30 June

30 June

31 Dec

Note

2022

 £

2021

£

2021

£

 

 

 

 

Revenue

1

352,713

373,306

701,435

Cost of sales

 

(272,808)

(356,530)

(599,914)

 

 

Gross profit

 

79,905

16,776

101,521

 

 

Administrative expenses

 

(1,050,400)

(1,115,481)

(2,147,476)

Acquisition costs

 

-

-

(11,735)

Share of associate

49,694

-

50,062

 

Operating loss

 

(920,801)

(1,098,705)

(2,007,628)

 

 

Net finance revenues

 

21,434

403

10,987

 

 

Loss before taxation

 

(899,367)

(1,098,302)

(1,996,641)

Income tax credit/(charge)

 

(9,273)

-

126,145

 

 

Loss after taxation

 

(908,640)

(1,098,302)

(1,870,496)

 

 

Total comprehensive loss

 

(908,640)

(1,098,302)

(1,870,496)

 

 

 

Total comprehensive loss attributable to:

 

 

Owners of the Company

 

(908,640)

(1,098,302)

(1,870,496)

Non-controlling interests

 

-

-

-

 

 

Loss per share from continuing operations (pence)

3

(0.02)

(0.03)

(0.05)

The notes numbered 1 to 5 are an integral part of the interim financial information.

Statement of Financial Position

 

(Unaudited)

As at

30 June

(Unaudited)

As at

30 June

(Audited)

As at

31 December

Note

2022

£

2021

£

2021

£

ASSETS

 

 

 

Non-current assets

 

 

 

 

Intangible fixed assets

 

43,654,220

43,543,569

43,554,498

Tangible fixed assets

 

23,901

46,237

33,092

Investments in subsidiary undertakings

 

1

1

1

Investments in associated undertakings

 

179,026

49

140,540

 

 

Total non-current assets

 

43,857,148

43,589,856

43,728,131

 

 

 

Current Assets

 

 

Loans receivable

 

1,925,112

1,152,928

1,165,286

Trade and other receivables

 

1,441,287

529,699

963,648

Corporation tax recoverable

 

-

19,571

155,227

Cash and cash equivalents

 

7,536,341

10,983,386

9,637,460

Total current assets

 

10,902,740

12,685,584

11,921,621

 

 

Total assets

 

54,759,888

56,275,440

55,649,752

 

 

 

LIABILITIES

 

Current liabilities

 

 

Creditors: amounts falling due within one year

 

(601,186)

(636,923)

(563,781)

Total current liabilities

 

(601,186)

(636,923)

(563,781)

Total assets less current liabilities

 

54,158,702

55,638,517

55,085,971

Creditors: amounts falling due after more than one year

 

-

(10,853)

-

Net assets/(liabilities)

 

54,158,702

55,627,664

55,085,971

 

 

 

EQUITY

 

 

Shares and stock

2

22,900,856

22,723,355

22,900,856

Share premium

 

61,291,710

61,143,215

61,291,710

Merger relief reserve

 

36,117,711

36,117,711

36,117,711

Accumulated deficit

 

(66,151,575)

(64,356,617)

(65,224,306)

 

 

Total surplus

 

54,158,702

55,627,664

55,085,971

 

 

 

 

 

The notes numbered 1 to 5 are an integral part of the interim financial information.

Statement of Cash Flows

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Six months

Six months

Year ended

 

 

ended

ended

31

Note

 

30 June

30 June

December

 

 

2022

£

2021

£

2021

£

Cash flows from operating activities

 

 

 

Operating loss

 

 

(920,801)

(1,098,705)

(2,007,628)

Adjustments for:

 

 

 

 

- Share based payments

 

(18,629)

17,329

34,829

- Amortisation

 

4,810

2,216

5,049

- Depreciation

 

11,021

13,747

28,824

- Goodwill impairment

 

-

-

-

- Share of associate result

 

(49,694)

-

(50,062)

- Provision against investments

 

-

-

49

Changes in working capital:

 

 

 

- Decrease/(increase) in contract costs

- Decrease/(increase) in trade and other receivables

 

 

-

(477,639)

14,550

(329,389)

14,550

(763,338)

- Increase/(decrease) in trade and other payables

 

 

50,007

126,854

55,015

Tax credits received

 

155,227

118,926

118,927

 

 

 

Net cash used in operations

 

 

(1,245,698)

(1,134,472)

(2,563,785)

Cash flows from investing activities

 

 

 

Loans advanced

 

(737,520)

(1,150,000)

(1,150,000)

Purchase of interest in associate

 

-

-

(99,990)

Dividends received from associate

 

1,935

-

-

Purchase of intangible fixed assets

 

(104,532)

(26,203)

(39,965)

Purchase of tangible fixed assets

 

(1,830)

(6,964)

(8,896)

 

 

Net cash from investing activities

 

 

(841,947)

(1,183,167)

(1,298,851)

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Proceeds from issue of shares

 

 

-

9,850,801

10,063,802

Payments of principal under leases

 

 

(12,602)

(11,726)

(23,882)

Net finance costs

 

 

(872)

(2,525)

(4,299)

 

 

 

Net cash flows from financing activities

 

 

(13,474)

9,836,550

10,035,621

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

(2,101,119)

7,518,911

6,172,985

 

 

Cash and cash equivalents at beginning of period

 

9,637,460

3,464,475

3,464,475

 

 

 

Cash and cash equivalents at end of period

 

 

7,536,341

10,983,386

9,637,460

 

 

 

 

The notes numbered 1 to 5 are an integral part of the interim financial information.

 

 

Statement of Changes in Equity

 

Ordinary Share capital

£

 

Deferred shares

£

Share premium

account

£

Merger relief

reserve

£

Accumulated

deficit

£

 

Total

£

 

Balance at 1 Jan 2021 (audited)

18,575,503

3,113,785

52,594,934

36,117,711

(63,544,097)

46,857,836

Transactions with equity participants:

- Shares issued on exercise options

24,477

-

174,603

-

-

199,080

- Shares issued on exercise warrants

100,500

-

105,487

-

-

205,987

- Other share issues

909,091

-

9,090,909

-

-

10,000,000

Share based payment

-

-

-

-

285,782

285,782

Share issue costs

-

-

(822,718)

-

-

(822,718)

Total comprehensive loss

-

-

-

-

(1,098,302)

(1,098,302)

Balance at 30 June 2021 (unaudited)

19,609,571

3,113,785

61,143,215

36,117,711

(64,356,617)

55,627,665

Transactions with equity participants:

- Shares issued on exercise options

177,500

-

148,495

-

-

325,995

Share based payment

-

-

-

-

(95,495)

(95,495)

Total comprehensive loss

-

-

-

-

(772,194)

(772,194)

Balance at 31 Dec 2021 (audited)

19,787,071

3,113,785

61,291,710

36,117,711

(65,224,306)

55,085,971

Share based payment

-

-

-

-

(18,629)

(18,629)

Total comprehensive loss

-

-

-

-

(908,640)

(908,640)

 

 

 

 

 

 

Balance at 30 June 2022 (unaudited)

19,787,071

3,113,785

61,291,710

36,117,711

(66,151,575)

54,158,702

 

 

 

 

 

 

 

 

The following describes the nature and purpose of each reserve within equity:

 

Share capital: Deferred shares: Represents the combined total of all deferred shares (0.5p, 4p and 4.5p)

 

Share premium: Amount subscribed for share capital in excess of nominal value

 

Merger relief reserve: Amount subscribed for share capital in excess of nominal value where merger relief applies

 

Accumulated deficit: Accumulated deficit represents the cumulative losses of the company and all other net gains and losses and transactions with shareholders not recognised elsewhere

 

The notes numbered 1 to 5 are an integral part of the interim financial information.

 

Notes (forming part of the interim financial information)

 

1. Summary of significant accounting policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the financial information.

 

1.1. Basis of preparation

This interim financial information is for the six months ended 30 June 2022 and has been prepared in accordance with International Accounting Standard 34 "Interim Financial Statements". The accounting policies applied are consistent with International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board (IASB) as adopted for use in the United Kingdom and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS (except as otherwise stated). The accounting policies and methods of computation used in the interim financial information are consistent with those of the previous financial year and corresponding interim reporting period and with those expected to be applied for the year ending 31 December 2022.

 

The Company does not consider any new and amended standards that became applicable for the current reporting period to have any impact on the Company's results.

 

The unaudited results for period ended 30 June 2022 do not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006. The comparative figures for the period ended 31 December 2021 for the Company are extracted from the audited financial statements which contained an unqualified audit report and did not contain statements under Sections 498 to 502 of the Companies Act 2006.

 

This interim financial statement will be, in accordance with the AIM Rules for Companies, available shortly on the Company's website.

 

1.2. Going concern

The Directors have considered all available information about future events when considering going concern. The Directors have prepared and reviewed cash flow forecasts for 12 months following the date of these Financial Statements. The projections show that the Company will have sufficient funding to be able to continue as a going concern on the basis of its cash balances as at 30 June 2022. 

 

The interim financial statements do not include the adjustments that would result if the Company were unable to continue as a going concern.

 

1.3. Functional and presentational currency

This interim financial information is presented in £ sterling which is the Group's functional currency.

 

1.4. Associated undertakings

Associates are entities which the Company has significant influence but not control or joint control as defined under IAS 28. This is generally the case where the Company holds between 20% and 50% of the voting rights. Investments in associates are accounted for using the equity method of accounting.

 

Under the equity method of accounting, investments are initially recognised at cost and adjusted thereafter to recognise the Company's share of the post-acquisition profits or losses of the investee in the Income statement. Dividends received or receivable from associates and joint ventures are recognised as a reduction in the carrying value of the investment.

 

When the Company's share of losses in an equity-accounted investment exceeds or equals its interest in the equity, the Company does not recognise further losses, unless it has incurred obligations or made payments on behalf of the other entity. Unrealised gains on transactions between the Company and its associates and joint ventures are eliminated to the extent of the Company's interest in these entities. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment in the asset transferred.

 

1.5. Revenue

The Company provides engineering services for the application of the DMG technology, the intellectual property that the Company owns. Revenue from providing services is recognised in the accounting period in which services are rendered. For fixed-price contracts, revenue is recognised based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided to the extent to which the customer receives the benefits. This is determined based on the actual labour hours spent relative to the total expected labour hours.

 

Where contracts include multiple performance obligations as specified by the work scope, the transaction price will be allocated to each performance obligation based on estimated expected cost-plus margin.

 

Estimates of revenues, costs, or extent of progress toward completion of services are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

 

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognised. If the payments exceed the services rendered, a contact liability is recognised.

 

If a contract includes an hourly fee, revenue is recognised in the amount to which the Company has a right to invoice.

 

2. SHARE CAPITAL

 

0.5 p Ordinary shares

0.5p Deferred

 shares

4.5 p Deferred shares

4.0 p Deferred shares

Balance at 1 January 2022

3,957,414,135

388,496,747

17,373,523

9,737,353

Shares issued

-

-

-

-

Balance at 30 June 2022

3,957,414,135

388,496,747

17,373,523

9,737,353

 

The deferred shares have no voting rights and do not carry any entitlement to attend general meetings of the Company. They carry only a right to participate in any return of capital once an amount of £100 has been paid in respect of each ordinary share. The Company is authorised at any time to affect a transfer of the deferred shares without reference to the holders thereof and for no consideration.

 

3. Loss per share

 

 

(Unaudited)

As at

30 June

(Unaudited)

As at

30 June

(Audited)

As at

31 December

2022

£

2021

£

2021

£

 

Total comprehensive loss

 

(908,640)

 

(1,098,302)

 

(1,870,496)

 

Weighted average number of shares

 

3,957,414,135

 

3,893,534,880

 

3,918,497,299

 

Basic loss per share in pence

(0.02)

(0.03)

(0.05)

Diluted loss per share in pence

(0.02)

(0.03)

(0.05)

 

 

4. SHARE BASED PAYMENT

 

The expense recognised for share-based payments during the year is shown in the following table:

 

(Unaudited)

As at

30 June

2022

£

(Unaudited)

As at

30 June

2021

£

(Audited)

As at

31 December

2021

£

Share based payment charge/(credit) recognised in Income Statement

 

 

Expense arising from equity-settled share-based payment transactions:

 

 

 - Share options for Directors and employees

(18,629)

17,329

34,829

Total share-based payment in Income Statement

(18,629)

17,329

34,829

 

Share based payment charge recognised in Share Premium

 

- Warrants for third party services

-

419,138

419,138

Total share-based payment in Share Premium Account

-

419,138

419,138

 

Total share-based payment charges/(credits) recognised

(18,629)

436,467

453,967

 

Other share-based payment movements

 

Exercise of options by Directors and employees

-

(73,987)

(186,982)

Exercise of warrants for third party services

-

(76,698)

(76,698)

Total share-based payment

(18,629)

285,782

190,287

 

The were no liabilities recognised in relation to share based payment transactions.

 

5. EVENTS AFTER THE REPORTING PERIOD

 

There are no events arising after the end of the reporting period to report in respect of the interim financial information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BCGDIBGDDGDS
Date   Source Headline
16th Apr 20247:00 amRNSTechnical Centre Update
18th Mar 20247:00 amRNSSubsidiary Contract
11th Mar 20247:00 amRNSUpdate on Longford Project JV
22nd Feb 20247:00 amRNSFramework Agreement with National Hydrogen
19th Feb 202412:32 pmRNSCorporate Activity Update
6th Feb 20245:20 pmRNSUpdate on European Patent Claim
31st Jan 20247:00 amRNSAppointment of Nominated & Financial Adviser
12th Dec 20237:00 amRNSDirector’s Dealing
11th Dec 20237:00 amRNSDirector’s Dealing
8th Dec 20237:00 amRNSDirectorate Update
27th Nov 20237:00 amRNSDirectorate Update
15th Nov 20237:00 amRNSDirectorate Change
6th Nov 20237:00 amRNSEuropean Patent update
30th Oct 20237:00 amRNSDeferral of Commitment to JV with HUI
6th Oct 20232:16 pmRNSPowerhouse Technology Centre Project Update
15th Sep 20237:00 amRNSEuropean Patent Grant Confirmed
7th Sep 20234:05 pmRNSResult of AGM
6th Sep 20237:05 amRNSHalf Year Report
6th Sep 20237:00 amRNSChange of directorate
22nd Aug 20237:00 amRNSPlacing to raise £1,000,000 and issue of equity
16th Aug 20237:00 amRNSNotice of AGM
13th Jul 20237:00 amRNSEuropean Patent Application Allowed
30th Jun 20237:00 amRNSAudited Results for Year Ended 31 December 2022
22nd Jun 20237:00 amRNSAcquisition of entire shareholding of Engsolve Ltd
30th May 20237:00 amRNSAppointment of representative in Northern Ireland
2nd May 20237:00 amRNSAcquisition of the entire shareholding of Protos
3rd Apr 20237:00 amRNSExtension of agreements with Peel
31st Mar 20237:00 amRNSPHE discussions with National Hydrogen Australia
21st Mar 20237:00 amRNSJoint Venture with HUI Plc
16th Mar 20239:00 amRNSCompletion of lease on Technology Centre
27th Feb 20237:00 amRNSHolding(s) in Company
27th Feb 20237:00 amRNSHolding(s) in Company
27th Feb 20237:00 amRNSHolding(s) in Company
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
22nd Feb 202311:05 amRNSSecond Price Monitoring Extn
22nd Feb 202311:00 amRNSPrice Monitoring Extension
22nd Feb 20237:00 amRNSFramework Services agreement with Petrofac
16th Feb 202311:05 amRNSDirectorate Change
23rd Jan 202312:27 pmRNSUpdate on Konin facility, Poland
12th Jan 202311:05 amRNSSecond Price Monitoring Extn
12th Jan 202311:00 amRNSPrice Monitoring Extension
11th Jan 20234:40 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Dec 20227:00 amRNSDirectorate Changes and Operational Update
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.